F
Fuyuki Okamoto
Researcher at Kyushu University
Publications - 16
Citations - 589
Fuyuki Okamoto is an academic researcher from Kyushu University. The author has contributed to research in topics: Cytokine & MAPK/ERK pathway. The author has an hindex of 10, co-authored 14 publications receiving 533 citations.
Papers
More filters
Journal ArticleDOI
Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Ludwine Messiaen,S. Yao,Hilde Brems,Tom Callens,Achara Sathienkijkanchai,Ellen Denayer,Emily Spencer,Pamela Arn,Dusica Babovic-Vuksanovic,Carolyn Bay,Gary Bobele,Bruce H. Cohen,Luis F. Escobar,Deborah L. Eunpu,Theresa A. Grebe,Robert M. Greenstein,Rachel K. Hachen,Mira Irons,David Kronn,Edmond G. Lemire,Kathleen A. Leppig,Cynthia Lim,Marie T. McDonald,Vinodh Narayanan,Amy Pearn,Robert Pedersen,Berkley R. Powell,Lawrence R. Shapiro,David Skidmore,David Tegay,Heidi Thiese,Elaine H. Zackai,Raymon Vijzelaar,Koji Taniguchi,Koji Taniguchi,Toranoshin Ayada,Fuyuki Okamoto,Akihiko Yoshimura,Akihiko Yoshimura,Annabel H. A. Parret,Bruce R. Korf,Eric Legius +41 more
TL;DR: A high SPRED1 mutation detection rate was found in NF1 mutation-negative families with an autosomal dominant phenotype of CALMs with or without freckling and no other NF1 features, and NFLS was not associated with the peripheral and central nervous system tumors seen inNF1.
Journal ArticleDOI
TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral Pathway *
Ryoko Yoshida,Giichi Takaesu,Giichi Takaesu,Hideyuki Yoshida,Fuyuki Okamoto,Tomoko Yoshioka,Yongwon Choi,Shizuo Akira,Taro Kawai,Akihiko Yoshimura,Akihiko Yoshimura,Takashi Kobayashi,Takashi Kobayashi +12 more
TL;DR: TRAF6 is demonstrated to be critical for IFN-α/β induction in response to viral infection and intracellular double-stranded RNA, poly(I:C), and data suggest that IPS-1 requires TRAF6 and MEKK1 to activate NF-κB and mitogen-activated protein kinases that are critical for the optimal induction of type I interferons.
Journal ArticleDOI
Suppressor of cytokine signaling 1 protects mice against concanavalin A–induced hepatitis by inhibiting apoptosis
Takehiro Torisu,Mako Nakaya,Satoko Watanabe,Masayuki Hashimoto,Hideyuki Yoshida,Takatoshi Chinen,Ryoko Yoshida,Fuyuki Okamoto,Toshikatsu Hanada,Kumiko Torisu,Giichi Takaesu,Takashi Kobayashi,Hideo Yasukawa,Akihiko Yoshimura +13 more
TL;DR: It is demonstrated that SOCS1 deletion in hepatocytes enhanced concanavalin A (ConA)–induced hepatitis and that forced expression of SOCS 1 is therapeutic in preventing hepatitis, indicating that SOCs1 plays important negative roles in fulminant hepatitis.
Journal ArticleDOI
miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1.
Takuma Ishizaki,Taiga Tamiya,Koji Taniguchi,Rimpei Morita,Reiko Kato,Fuyuki Okamoto,Kazuko Saeki,Masatoshi Nomura,Yoshihisa Nojima,Akihiko Yoshimura +9 more
TL;DR: Results suggest that Spred1 negatively regulates mast cell activation, which is modulated by microRNA‐126, a miRNA located within the Egfl7 gene, and is involved in the regulation of vessel development through its role in regulating VEGF signaling.
Journal ArticleDOI
Leukotriene B4 augments and restores FcγRs-dependent phagocytosis in macrophages
TL;DR: Surprisingly, it is found that LTB4-BLT1 signaling restores phagocytosis in the absence of FcγRs signaling.